VIA
PROK icon

Virtus Investment Advisers’s ProKidney PROK Stock Holding History

Virtus Investment Advisers’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221K Buy
123,388
+3,012
+3% +$6.39K 0.06% 329
2025
Q4 		$270K Buy
+120,376
New +$317K 0.07% 295

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Virtus Investment Advisers's PROK Position: Q1 2026 in Review

Virtus Investment Advisers increased its ProKidney (PROK) stake by 2.5% in Q1 2026, buying an estimated $6.39K and bringing the position to 123,388 shares worth $221K. The position accounts for 0.06% of the portfolio, ranked #329.

Virtus Investment Advisers first reported a position in PROK in Q4 2025 and has held it in 2 quarters since. The position peaked at $270K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Virtus Investment Advisers held 123,388 shares of ProKidney worth $221K as of Q1 2026.
  • Virtus Investment Advisers bought 3,012 ProKidney shares in Q1 2026, an estimated $6.39K.
  • ProKidney made up 0.06% of Virtus Investment Advisers's portfolio in Q1 2026, its #329 holding.
  • Virtus Investment Advisers first reported a position in ProKidney in Q4 2025 and has held it in 2 quarters since.
  • Virtus Investment Advisers's ProKidney position peaked at $270K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.